CAS: 80696-30-6; (R)-2-Aminopentan-1-Ol

该化合物是一种氨基酒精,是氨基酸醋的衍生物,其特点是碳链中附带的氢氧基(-OH),有助于将其分类为酒精.D-Norvalinol的特征是其个性性性,拥有一个立体中心,允许存在对映体.这种化合物一般没有色,并且可能溶于水中,因为存在会增加其极性的氢氧基组.D-Norvalinol在各个领域,包括药物合成和生物化学领域,具有潜在用途,是更复杂的分子的建筑块.其结构特性使其能够参与各种化学反应,包括消毒和授精.此外,氨基组的存在使其与生物系统有关,在代谢途径中可以发挥作用,或作为其他生物活性化合物的前体.

结构式图片

相似化合物

2025376-01-4 22724-81-8 40918-51-2

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号2013-12-9 D-正缬氨酸 | CAS号4146-04-7 DL-2-氨基-1-戊醇 | CAS号62421-33-4 1-(4-methylphen...

合成工艺路线路线简述

    📜D-正缬氨酸置于lithium Aluminium Tetrahydride体系中,用 四氢呋喃 作为反应溶剂,化学反应 2.0H,以63%的收率获得产物(R)-(-)-2-氨基-1-戊醇
    参考文献:对映选择性合成和绝对构型的(-)-1-(苯并呋喃-2-基)-2-丙基氨基戊烷((-)-Bpap),一种高效的选择性儿茶酚胺能增强剂.
    标题:对映选择性合成和绝对构型的(-)-1-(苯并呋喃-2-基)-2-丙基氨基戊烷((-)-Bpap),一种高效的选择性儿茶酚胺能增强剂.
    摘要:描述了(-)-1-(苯并呋喃-2-基)-2-丙基氨基戊烷((-)-Bpap)的对映选择性合成和绝对构型,这是一种高效且选择性的儿茶酚胺能活性增强剂(cae)物质.合成方法包括苯并呋喃与(R)-N-甲苯磺酰基-2-丙基叠氮嗪或(R)-N-甲氧基-N-甲基降甲酰胺的偶联反应,然后对所得偶联产物进行适当的修饰.结果,(-)-Bpap证明具有r构型,其最终通过x射线晶体学分析得到证实.
    DOI:10.1016/s0968-0896(00)00341-2

    海关参考信息

    专利信息


    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-2004106598-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005192269-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2005267150-A1
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-6569851-B1
    优先权日:1998-06-22
    标 题 :Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1055/s-0031-1289531
    摘要:Chemla F, Cyklinsky M, Botuha C, Ferreira F, Pérez-Luna A. Diastereoselective Synthesis of Enantiopure Homopropargylic N-tert-Butylsulfinylamines. Synlett. 2011 Oct 19;2011(18):2681–4. doi: 10.1055/s-0031-1289531.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知